SINGULAIR - 54569-4736-0 - (montelukast sodium)

Alphabetical Index


Drug Information of SINGULAIR

Product NDC: 54569-4736
Proprietary Name: SINGULAIR
Non Proprietary Name: montelukast sodium
Active Ingredient(s): 5    mg/1 & nbsp;   montelukast sodium
Administration Route(s): ORAL
Dosage Form(s): TABLET, CHEWABLE
Coding System: National Drug Codes(NDC)

Labeler Information of SINGULAIR

Product NDC: 54569-4736
Labeler Name: A-S Medication Solutions LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020830
Marketing Category: NDA
Start Marketing Date: 20001110

Package Information of SINGULAIR

Package NDC: 54569-4736-0
Package Description: 30 TABLET, CHEWABLE in 1 BOTTLE, DISPENSING (54569-4736-0)

NDC Information of SINGULAIR

NDC Code 54569-4736-0
Proprietary Name SINGULAIR
Package Description 30 TABLET, CHEWABLE in 1 BOTTLE, DISPENSING (54569-4736-0)
Product NDC 54569-4736
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name montelukast sodium
Dosage Form Name TABLET, CHEWABLE
Route Name ORAL
Start Marketing Date 20001110
Marketing Category Name NDA
Labeler Name A-S Medication Solutions LLC
Substance Name MONTELUKAST SODIUM
Strength Number 5
Strength Unit mg/1
Pharmaceutical Classes Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]

Complete Information of SINGULAIR


General Information